| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2013 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SHERWIN WILLIAMS CO | 36 | Q3 2023 | 6.0% |
| UNITEDHEALTH GROUP INC | 36 | Q3 2023 | 4.1% |
| APPLE INC | 36 | Q3 2023 | 3.8% |
| INTERNATIONAL BUSINESS MACHS | 36 | Q3 2023 | 3.5% |
| CBOE HLDGS INC | 36 | Q3 2023 | 1.1% |
| META PLATFORMS INC | 36 | Q3 2023 | 0.8% |
| JPMORGAN CHASE & CO | 35 | Q3 2023 | 2.9% |
| BERKSHIRE HATHAWAY INC DEL | 34 | Q3 2023 | 4.6% |
| ABBVIE INC | 33 | Q3 2023 | 3.5% |
| JOHNSON & JOHNSON | 33 | Q3 2023 | 1.1% |
View GYROSCOPE CAPITAL MANAGEMENT GROUP, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-04-21 |
| 13F-HR | 2022-02-04 |
| 13F-HR | 2021-10-15 |
| 13F-HR | 2021-07-15 |
View GYROSCOPE CAPITAL MANAGEMENT GROUP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.